Research

Browse Research Content

CHPA supports the Agency’s directive to increase enrollment of participants from historically underrepresented populations in clinical trials to improve the strength and generalizability of the evidence to demonstrate safety and/or effectiveness of FDA-regulated medical products, but requests clarification on several points.

Oct 29, 2024

In this episode, Health In Hand Foundation Executive Director Mary Leonard and PatientPoint's Chief Client Officer Linda Ruschau discuss the importance of education to drive empowerment and informed decision-making.

Jan 17, 2024

Millions of Americans rely on OTC medicines. Following the COVID-19 pandemic, OTCs have become an even more essential part of the treatment toolbox. Today, we take a look at the value created by OTC medicines as we walk through some of the top findings from CHPA's latest OTC value study.

Apr 10, 2023

The purpose of this cybersecurity and data privacy regulatory scan is to understand the current and forthcoming regulatory landscape related to cybersecurity and consumer data privacy.

Jan 20, 2023

New data-driven tool will help CHPA educate stakeholders on the role of dietary supplements in healthcare.

Mar 21, 2022

We don't often think about insurance coverage for OTC medicines, but more and more health plans are offering this benefit. In this episode, we'll explore what new research is telling us about this and why Medicare Advantage is a big opportunity for self-care.

Mar 21, 2022

OTC programs strengthen member acquisition, retention, satisfaction, and care management strategies.

Nov 2, 2021

The Medicare Advantage health insurance market represents an attractive and rapidly growing opportunity in the Consumer Healthcare and OTC Medicines industry.

Nov 2, 2021

Filter Results